论文信息 - Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients. - 字舞流文

Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients.

D. Renlund | R. Shaddy | M. Bristow | D. Taylor | L. Tani | S. Olsen | E. A. Bullock | Olsen Sl | D. O. Taylor | E. Bullock

[1] M. Bristow. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. , 1993, The American journal of cardiology.

[2] S. Colan,et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.

[3] H. Valantine,et al. Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. , 1989, Circulation.

[4] M. Rich,et al. Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity. Report of three cases. , 1987, Annals of internal medicine.

[5] S. Sallan,et al. Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in children , 1981, Cancer.

[6] Daniels,et al. Clinical spectrum of anthracycline antibiotic cardiotoxicity. , 1978, Cancer treatment reports.